欢迎来到《四川大学学报(医学版)》

Spartin和白脂素在糖尿病心脏微血管内皮损伤中的作用及其机制探讨

Study of the Role and Mechanism of Asprosin/Spartin Pathway in Cardiac Microvascular Endothelial Injury Induced by Diabete Mellitus

  • 摘要:
      目的  探讨spartin和白脂素(Asp)在高糖性心脏微血管内皮(CMECs)细胞损伤中的作用及其作用机制。
      方法  培养小鼠CMECs,将其分为正常组(葡萄糖浓度为5.5 mmol/L)和高糖组(HG组, 葡萄糖浓度为30 mmol/L),实时荧光定量PCR(qRT-PCR)及Western blot分别检测CMECs痉挛性截瘫基因20型(spastic paraplegia 20,SPG20) mRNA和spartin蛋白的表达。利用腺病毒(Ad)转染上调spartin表达、小干扰RNA(siRNA)转染下调,采用抗氧化剂N-乙酰半胱氨酸(NAC)、Asp对下调了spartin表达、并在48 h后用30 mmol/L葡萄糖干预24 h的CMECs进行干预,采用流式细胞学技术检测各组细胞凋亡率,一氧化氮(nitric oxide, NO)荧光探针染色检测NO的生成、超氧化物阴离子荧光探针染色及ELISA试剂盒检测细胞内活性氧簇(reactive oxygen species, ROS)的生成。建立2型糖尿病(type 2 diabetes mellitus, T2DM)小鼠模型,分为T2DM组和T2DM+Asp组,模型建立成功后(随机血糖大于16.7 mmol/L)予以Asp(1 μg/g)每天腹腔注射1次,2周后小鼠心脏超声检查心脏舒张功能,心脏微血管腐蚀铸型后扫描电镜观察心脏微血管内皮完整性。
      结果  与正常组相比,HG组小鼠CMECs中SPG20 mRNA及spartin蛋白表达均降低(P < 0.05)。在HG培养条件下,Ad感染后CMECs内ROS含量减少(P < 0.05),细胞凋亡水平降低(P < 0.05),NO生成增加;相反,siRNA干预后得到相反的结果。NAC能够部分逆转siRNA的上述作用。Asp能够上调CMECs SPG20 mRNA及spartin蛋白表达,减少ROS的生成,减少细胞凋亡,增加NO的生成,但下调spartin后给予Asp干预,Asp减少ROS生成、减少CMECs凋亡、NO生成增加效应被部分逆转。体内实验发现,Asp可改善2型糖尿病模型小鼠心脏功能和增加心脏微血管内皮的完整性和光滑性。
      结论  Asp可通过上调spartin表达途径抑制CMECs内的氧化应激反应,从而减轻糖尿病心脏微血管内皮损伤。

     

    Abstract:
      Objective  To detect the effects and mechanism of asprosin (Asp) and spartin on the injury of mice cardiac microvascular endothelial cells (CMECs) induced by high glucose.
      Methods  The cultured CMECs were divided into 2 groups, one group is normal group (5.5 mmol/L glucose in the medium) and another is HG group (30 mmol/L glucose in the medium). Real-time PCR (qRT-PCR) and Western blot were respectively used to detect the mRNA level of spastic paraplegia 20 (SPG20) and protein expression of spartin in CMECs. Upregulation or downregulation of the expression of spartin was achieved via transfection with adenovirus (Ad) or small interfering RNA (siRNA) respectively. CMECs with downregulation of spartin expression were firstly treated with anti-oxidant N-acetylcysteine (NAC) or Asp respectively for 48 h, and then were interfered with 30 mmol/L glucose for 24 h afterward. The apoptosis of cell was detected by flow cytometry. Nitric oxide (NO) production was detected by NO probe and ELISA kit. The intracellular reactive oxygen species (ROS) levels were tested by DHE staining and ELISA kit. Type 2 diabetic model mice were established and then divided into T2DM group and T2DM+Asp group. After the model mice were established successfully (random blood glucose was more than 16.7 mmol/L), Asp (1 μg/g) was intraperitoneally injected once a day. After 2 weeks, mice echocardiography was performed to test cardiac diastolic function. The integrity of the microvascular endothelium was observed by scanning electron microscopy.
      Results  Compared with the normal group, the mRNA level of SPG20 and protein expression of spartin in mice CMECs of HG group were significantly reduced (P < 0.05). Under the condition of high glucose, Ad transfection induced significant decrease of the intracellular ROS level and the apoptosis level of the CMECs (P < 0.05), while NO increased after Ad transfection. In contrast, siRNA intervention resulted in opposite effect. In addition, the antioxidant NAC partly reversed the above changes caused by downregulating spartin. Asp upregulated the level of SPG20 mRNA and spartin protein expression in CMECs, reduced ROS production, reduced apoptosis and increased NO production. However, intervention effects of Asp, such as decreasing of ROS production, inhibiting apoptosis of CMECs and increasing of NO production, were partly reversed in spartin downregulated cells. In vivo, we found that Asp can improve cardiac function and increase the integrity and smoothness of cardiac microvascular endothelium in type 2 diabetic mice.
      Conclusion  Asp can inhibit oxidative stress in mice CMECs through upregulating spartin signaling pathway, thereby alleviating the damage of microvascular endothelium in diabetic heart.

     

/

返回文章
返回